£995.00

The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City

Econometrics

Price data last checked 19 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£995 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 72 days · 72 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 72 days • 1 price levels

Days at Price

Price Analysis

Most common price: £995 (72 days, 100.0%)

Price range: £995 - £995

Price levels: 1 different prices over 72 days

Description

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major city of the world. It then ranks these cities and reports them in terms of their size as a percent of the country where they are located, their geographic region (e.g. Africa, Asia, Europe, Middle East, North America, Latin America), and the total world market. In performing various economic analyses for its clients, I have been occasionally asked to investigate the market potential for various products and services across cities. The purpose of the studies is to understand the density of demand within a country and the extent to which a city might be used as a point of distribution within its region. From an economic perspective, however, a city does not represent a population within rigid geographical boundaries. To an economist or strategic planner, a city represents an area of dominant influence over markets in adjacent areas. This influence varies from one industry to another, but also from one period of time to another. In what follows, I summarize the economic potential for the world's major cities for "Multiple Sclerosis therapeutics" for the year 2016. The goal of this report is to report my findings on the real economic potential, or what an economist calls the latent demand, represented by a city when defined as an area of dominant influence. The reader needs to realize that latent demand may or may not represent real sales. For many items, latent demand is clearly observable in sales, as in the case for food or housing items. Consider, however, the

Product Specifications

Format: paperback
ASIN: B00X37JGQQ
Category: Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain: Amazon UK
Release Date: 30 April 2015
Listed Since: 04 May 2015

The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City

The 2023 Report on Multiple Sclerosis Treatments: World Market Segmentation by City

The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India

The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis

Multiple Sclerosis - Pathways, Diagnosis and Therapeutic Targets (Nervous System and Mental Health)

Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments

Multiple Sclerosis in Children and Adolescents - Medical Book

Living with Multiple Sclerosis: A Group-Based Psychological Support Intervention for Newly Diagnosed People with MS (LiMS)

Translational Methods for Multiple Sclerosis Research: 166 (Neuromethods, 166)

Translational Methods for Multiple Sclerosis Research: 166 (Neuromethods, 166)

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan

Multiple Sclerosis

Clinical Aspects of Multiple Sclerosis Essentials and Current Updates

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis for US Zip Codes

Multiple Sclerosis: Present and Future: 16 (Ettore Majorana International Science Series, 16)

The 2023 Report on Psoriasis Medicines: World Market Segmentation by City

Emerging Drugs and Targets for Multiple Sclerosis: Volume 70 (Drug Discovery Series)

The 2023 Report on Advanced Therapy Medicinal Products: World Market Segmentation by City

New Insights into Systemic Sclerosis

Regulatory T cells and Multiple Sclerosis: Immunobiology of Treg cells in MS

Systemic Sclerosis - Recent Advances and New Perspectives

Springer - Diet and Multiple Sclerosis (MS) Research Book